Capital City Fruit Issues Recall of Cherry Tomatoes

Capital City Fruit Issues Recall of Cherry Tomatoes

Capital City Fruit Issues Recall of Cherry Tomatoes

On November 21, 2012, the Food and Drug Administration (FDA) announced that Capital City Fruit, Inc from Norwalk, Iowa is voluntarily recalling cherry tomatoes that were shipped to Rio Queen Citrus Inc on November 10, 2012.  The cherry tomatoes may be contaminated with Salmonella.  

The tomatoes were received and used in packaging of certain lots of Capital Brand Clamshell Cherry tomatoes.  The packaged items were shipped to retail stores between November 14, 2012 and November 18, 2012.  The products were distributed to stores in Iowa, Missouri, Illinois, Kansas, Nebraska, South Dakota, Minnesota and Wisconsin.  

There have been no illnesses reported in association with this recall so far.  The voluntary recall is intended to alert consumers and make stores remove the products from their shelves.  

The specific recalled product is called Capital Brand 1-pint clamshell container.  The affected lot numbers and their corresponding clamshell date code are listed below:

P96290001 / 4604
P96330002 / 4605
P96477001 / 4606
P96368001 / 4605
P96500001 / 4701
P96313001 / 4604
P96330007 / 4605
P96290006 / 4604
P96500006 / 4701

The label is located on the top of the container, and the date code is located on the lower, right-hand side of the container.  

Salmonella is particularly dangerous in children, the elderly, and people with weak immune systems because it can cause life-threatening infections.  Healthy people will often experience the following symptoms: fever, diarrhea (sometimes bloody), nausea, vomiting, and abdominal pain.  Salmonella can result in more serious complications in some cases (like arterial infections and arthritis), so you should contact your doctor immediately if you believe you’ve contracted Salmonella.  

Consumers should discard this item and show the receipt to the store for a refund.  Consumers can call Capital City Fruit, Inc at (800) 535-6826.  

Source: Food and Drug Administration




Related Articles

Read previous post:
Lyrica Lawsuit